References
- Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047–1056. doi:10.1161/CIRCULATIONAHA.118.037137
- Gulati R, Behfar A, Narula J, et al. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020;95(1):136–156. doi:10.1016/j.mayocp.2019.05.001
- Ong S-B, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87. doi:10.1016/j.pharmthera.2018.01.001
- Chen L, Han L, Luo J. Selection of percutaneous coronary intervention in elderly patients with acute myocardial infarction in tertiary hospital. Medicine. 2019;98(29):e16544. doi:10.1097/MD.0000000000016544
- Yang Q, Wang Y, Liu J, et al. Invasive management strategies and antithrombotic treatments in patients with Non-ST-segment-elevation acute coronary syndrome in China: findings from the improving CCC project (Care for cardiovascular disease in China). Circulation. 2017;10(6):e004750.
- Mancone M, Cavalcante R, Modolo R, et al. Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial. EuroIntervention. 2020;15(17):1520–1526. doi:10.4244/EIJ-D-19-00208
- Lunati A, Lesage S, Brice A. The genetic landscape of Parkinson’s disease. Rev Neurol. 2018;174(9):628–643. doi:10.1016/j.neurol.2018.08.004
- Truban D, Hou X, Caulfield TR, et al. PINK1, parkin, and mitochondrial quality control: what can we learn about parkinson’s disease pathobiology? J Parkinsons Dis. 2017;7(1):13–29. doi:10.3233/JPD-160989
- Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91–98. doi:10.1038/nchembio.2239
- Stoyanovsky DA, Tyurina YY, Shrivastava I, et al. Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med. 2019;133:153–161. doi:10.1016/j.freeradbiomed.2018.09.008
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
- Jones DA, Wright P, Alizadeh MA, et al. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021;7(5):398–404. doi:10.1093/ehjcvp/pvaa096
- Cheng P, Han H, Chen F, et al. Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor. Acta Biomater. 2022;140:481–491. doi:10.1016/j.actbio.2021.11.041
- Park M-W, Kim CJ, Kim M-C, et al. A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial. EuroIntervention. 2021;16(14):1170–1176. doi:10.4244/EIJ-D-20-00187
- Ma L, Pan Y, Wu Z, et al. Effect of tegretol on oxidative stress, serum inflammatory factors, and left ventricular function in AMI patients after emergency PCI. Comput Math Methods Med. 2022;2022:8929058. doi:10.1155/2022/8929058
- Tokarek T, Dziewierz A, Plens K, et al. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction. Hellenic J Cardiol. 2021;62(3):212–218. doi:10.1016/j.hjc.2021.01.011
- Yin K, Lee J, Liu Z, et al. Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production. Cell Death Differ. 2021;28(8):2421–2435. doi:10.1038/s41418-021-00760-9
- Zhao C, Chen Z, Xu X, et al. Pink1/Parkin-mediated mitophagy play a protective role in cisplatin induced renal tubular epithelial cells injury. Exp Cell Res. 2017;350(2):390–397. doi:10.1016/j.yexcr.2016.12.015
- Durga Devi T, Babu M, Mäkinen P, et al. Aggravated postinfarct heart failure in type 2 diabetes is associated with impaired mitophagy and exaggerated inflammasome activation. Am J Pathol. 2017;187(12):2659–2673. doi:10.1016/j.ajpath.2017.08.023
- Li J, Cao F, Yin H-L, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. doi:10.1038/s41419-020-2298-2
- Wang Y, Zhang M, Bi R, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 2022;51:102262. doi:10.1016/j.redox.2022.102262
- Liao P, Wang W, Wang W, et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365–378.e6. doi:10.1016/j.ccell.2022.02.003
- Ortiz VD, Türck P, Teixeira R, et al. Carvedilol and thyroid hormones co-administration mitigates oxidative stress and improves cardiac function after acute myocardial infarction. Eur J Pharmacol. 2019;854:159–166. doi:10.1016/j.ejphar.2019.04.024